- 全部删除
 
您的购物车当前为空
(S)-DI-87((S)-TRE-515)是DI-87的异构体。DI-87是一种新型和可口服的dCK(deoxycytidine kinase)抑制剂,具有良好的体外活性和低蛋白结合率,DI-87与dCK结合后,阻止dCK对脱氧胞苷的磷酸化反应,从而减少dNTP的生成和细胞周期停滞(特别是在S期)。与胸苷联合使用时,DI-87能显著抑制肿瘤生长。

(S)-DI-87((S)-TRE-515)是DI-87的异构体。DI-87是一种新型和可口服的dCK(deoxycytidine kinase)抑制剂,具有良好的体外活性和低蛋白结合率,DI-87与dCK结合后,阻止dCK对脱氧胞苷的磷酸化反应,从而减少dNTP的生成和细胞周期停滞(特别是在S期)。与胸苷联合使用时,DI-87能显著抑制肿瘤生长。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,300  | In stock | |
| 5 mg | ¥ 3,250  | In stock | |
| 10 mg | ¥ 4,750  | In stock | |
| 25 mg | ¥ 7,480  | In stock | |
| 50 mg | ¥ 9,870  | In stock | |
| 100 mg | ¥ 13,600  | In stock | |
| 200 mg | ¥ 18,300  | In stock | 
(S)-DI-87 相关产品
| 产品描述 | (S)-DI-87((S)-TRE-515) is an isomer of DI-87.DI-87 is a novel and orally available dCK (deoxycytidine kinase) inhibitor with good in vitro activity and low protein binding.DI-87 binds to dCK and prevents the phosphorylation of deoxycytidine by dCK, resulting in a reduction in dNTP production and cell cycle arrest ( especially in S phase). When combined with thymidine, DI-87 significantly inhibits tumor growth.  | 
| 别名 | (S)-TRE-515, (S)-DI87 | 
| 分子量 | 502.65 | 
| 分子式 | C23H30N6O3S2 | 
| CAS No. | 2107280-58-8 | 
| Smiles | [C@H](SC=1N=C(N)C=C(N)N1)(C)C=2N=C(SC2C)C3=CC(OCCN4CCOCC4)=C(OC)C=C3 | 
| 密度 | no data available | 
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容